Prognostic factors and treatment of patients with T‐cell non‐Hodgkin lymphoma
Maricer P. Escalón(The University of Texas MD Anderson Cancer Center), Nam H. Dang(University of Florida), Ying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Mark A. Hess(The University of Texas MD Anderson Cancer Center), Terry L. Smith(Virginia Commonwealth University), Pamela L. Walker(The University of Texas MD Anderson Cancer Center), Nina S. Liu(The University of Texas MD Anderson Cancer Center)
Cited by 227
Related Papers
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.
|PubMed|1988|218
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia
|Blood|2020|139
Prognostic factors in acute leukemia.
|PubMed|1976|112
Complete Remissions in Metastatic Breast Cancer Treated with Combination Drug Therapy
|Annals of Internal Medicine|1979|92
Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement
|Proceedings of the National Academy of Sciences|2017|86